Dimitris Polygenis - McKesson Canada

Dimitris Polygenis

PRESIDENT, BIOPHARMA AND PAYER SOLUTIONS, MCKESSON CANADA

Dimitris Polygenis is President, Biopharma and Payer Solutions. In this role, Mr. Polygenis is focused on strengthening our biopharma offerings and enhancing our payer partnerships while delivering increased value to patients, providers, insurers, and biopharma partners.

Mr. Polygenis joined McKesson Canada in 2005, after the acquisition of Phase 4 Health, a specialty and manufacturer-facing services company he helped build and grow. This acquisition led to the creation of McKesson Specialty Health, offering a wide range of services to manufacturers. Under his leadership, the group expanded its services to become Canada’s largest specialty services provider and McKesson Canada’s fastest-growing business unit. During his time with McKesson, he has led almost every business unit in the Canadian portfolio. A pharmacist by training, Mr. Polygenis is known as a strategic business leader committed to customer success, driving operational excellence, and building high-performing teams.

Prior to joining McKesson Canada, Mr. Polygenis served as a health care consultant to numerous industry stakeholders, including a position with the Ontario Round Table on Appropriate Prescribing (ORTAP) at the Institute for Clinical Evaluative Sciences in Ontario (ICES). He has held multiple teaching and board-appointments, including University of Toronto and University of British Columbia Pharmacy Programs, Neighbourhood Pharmacy Association of Canada (NPAC), Canadian Association for Pharmacy Distribution Management (CAPDM) and the Country Day School.